• Are ASX 200 bank stocks a buy in October?

    Four business people wearing formal business suits and ties walk abreast on a wide paved surface with their long shadows falling on the ground ahead of them.

    September was a mixed month for S&P/ASX 200 Index (ASX: XJO) bank shares.

    Some ASX bank stocks experienced a pullback over the past month, while others started trending higher. 

    It looks like investors aren’t sure what to make of rising inflation, higher interest rates, a weakening housing market, all against a backdrop of macroeconomic pressures and broad-based uncertainty.

    What happened to the ASX 200 big four major banks in September?

    Australia’s banking sector is dominated by the big four banks: Commonwealth Bank of Australia (ASX: CBA), Westpac Banking Corp (ASX: WBC), National Australia Bank Ltd (ASX: NAB), and ANZ Group Holdings Ltd (ASX: ANZ).  

    Together, they make up around a quarter of the ASX 200 by market capitalisation. 

    There wasn’t any price sensitive news out of any of the big four banks in September, so share price fluctuations were due to shifts in investor sentiment.

    At the close of the last day of the month, CBA shares were around 0.5% higher to $151.01 each. But the ASX 200 major bank’s shares have dropped around 6% over the course of September. 

    NAB shares also ended the month in the green, up slightly by around 0.1% for the day on Wednesday, at $39.15 a piece. NAB shares have been relatively stable over the past month, and ended around 1% higher than they started. 

    ANZ shares, however, ended the last day of the month in the red. The shares fell around 0.5% to $38.31 on Wednesday afternoon, to $38.31 each. But over the past month, the bank stock has climbed around 3% higher.

    Meanwhile, Westpac shares ended around 0.2% higher on Wednesday afternoon, at $35.07 each. Over the past month, the shares have risen around 1.5%.

    What about the ASX 200 mid-tier banks?

    It was a similar story among the ASX 200 mid-tier banks too.

    Bendigo and Adelaide Bank Ltd (ASX: BEN) closed around 0.5% higher on the last day of September, at $10.36 each. Over the month the shares fell around 3%.

    Bank of Queensland Ltd (ASX: BOQ) shares climbed slightly into the green, up around 0.2% to $6.61. They were also up around 1% over the course of September. 

    While Macquarie Group Ltd (ASX: MQG) also tumbled around 0.5% on Wednesday, closing the month at $246.10 a piece. The bank shares were also down around 2% over the month.

    Which ASX bank shares are a buy for October?

    Macquarie shares were one of the poorest performing ASX bank shares in September. But it’s still the only stock that brokers are bullish about going forward. Market Index data shows that the majority have a strong buy rating on Macquarie shares. The average $270.89 target price implies the shares have the potential to climb another 10% higher, at the time of writing.

    Which ones have been rated as a sell?

    The experts have had a strong sell rating on CBA shares for some time now. And there hasn’t been a change in sentiment this month either. Market Index data shows the majority of brokers have a strong sell rating, and the $125.20 target price implies a downside of around 17%, at the time of writing. That’s the largest forecasted downside of any of the ASX banks.

    The experts also have a sell rating on Westpac shares. Market Index data shows the average $34.18 target price implies a downside of around 3%, at the time of writing.

    Brokers are also bearish on the outlook for Bendigo and Adelaide Bank shares. Market Index data shows the majority have a sell rating, and the $10.06 average target price also implies a downside of around 3%.

    And what shares do brokers rate as a hold?

    The data also shows that the majority have a hold rating on NAB shares. The $39.88 average target price implies the shares have the potential to climb slightly, by around 2%, over the next 12 months.

    It’s a similar story for ANZ shares. Most brokers also have a hold stance on the major bank, but after a slightly stronger September, the $36.05 average target price now suggests the shares could fall by up to 6% over the next 12 months, at the time of writing.

    BOQ shares are the last on the list. Again, the majority have a hold rating, and the $6.06 average target price implies a downside of around 8%, at the time of writing.

    The post Are ASX 200 bank stocks a buy in October? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Anz Group right now?

    Before you buy Anz Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Anz Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Bendigo And Adelaide Bank. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Should I buy DroneShield shares after its big US news?

    Woman looking at her computer and pondering something.

    DroneShield Ltd (ASX: DRO) shares are starting October around $1.70 after a jump on the final day of last month.

    Investors were buying the counter-drone technology company’s shares after it was awarded a major US procurement vehicle.

    Does that make the shares a buy in October?

    I think so, although investors need to be comfortable with plenty of volatility.

    What does the US win actually mean?

    DroneShield has been awarded an Indefinite Delivery, Indefinite Quantity contract supporting the US Joint Interagency Task Force 401 Domestic Shield initiative.

    The vehicle has a maximum value of US$500 million over three years and is designed to provide a streamlined way for the US government to procure DroneShield’s counter-drone capabilities.

    Importantly, that does not mean DroneShield has suddenly booked US$500 million of revenue.

    Individual orders still need to be awarded under the agreement, and DroneShield says it will announce material orders as they occur.

    For me, that distinction is important, but it does not take away from the significance of the announcement.

    DroneShield has already delivered DroneSentry-X Mk2 systems in support of JIATF-401 requirements, including systems that have been installed and accepted on US military vehicles. The new agreement gives the company another pathway to supply its technology as the US expands counter-drone protection across military installations and other priority locations.

    That is the sort of relationship I want to see developing.

    The valuation is demanding

    One thing that can’t be ignored is DroneShield’s valuation.

    Consensus forecasts currently point to earnings per share (EPS) of around 1 cent in FY28.

    At a $1.70 share price, that would put DroneShield shares on a PE ratio of roughly 170 times forecast FY28 earnings.

    That is clearly expensive by almost any conventional measure. But I am not convinced that figure tells us everything about the company’s longer-term earnings power.

    DroneShield is still investing heavily to become a much larger business. That includes manufacturing capacity, research and development, sales operations, and its international footprint.

    Those costs can constrain reported earnings today while potentially creating the capacity to generate much more revenue later.

    If US defence demand accelerates and DroneShield converts procurement vehicles like this one into substantial orders, I think profits could eventually scale much faster than the current EPS forecast suggests.

    Why I would still buy

    Counter-drone technology is becoming increasingly important as cheap and readily available drones change the nature of warfare and create new security challenges.

    DroneShield is positioning itself directly in that market with technology spanning detection, electronic countermeasures, command and control, and sensor integration.

    The latest US agreement gives me more confidence that its products are gaining traction with a strategically important customer.

    But I would expect the journey to be bumpy. Defence contracts can be large and irregular, expectations around DroneShield are already high, and a valuation of around 170 times FY28 forecast earnings leaves little room for disappointment.

    Foolish takeaway

    I would buy DroneShield shares around $1.70, but I would go in expecting volatility.

    The current earnings numbers make the shares look extremely expensive. For me, though, the bigger question is what earnings could look like once today’s investment starts translating into a much larger order book.

    The new US procurement vehicle does not guarantee that outcome, but I think it strengthens the case that DroneShield has a genuine opportunity to become a much larger defence technology business.

    The post Should I buy DroneShield shares after its big US news? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in DroneShield right now?

    Before you buy DroneShield shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and DroneShield wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Grace Alvino has positions in DroneShield. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Transurban Group share price: $4.5bn deal for bigger Sydney road stakes

    multiple road lanes with cars

    The Transurban Group (ASX: TCL) share price is in focus after announcing a $4.5 billion deal to acquire additional stakes in key Sydney toll road operators, boosting its interests in Westlink M7, NorthConnex, and WestConnex.

    What did Transurban Group report?

    • Agreed to acquire CPPIB’s 25% interest in NorthWestern Roads Group (Westlink M7, NorthConnex)
    • Also acquiring a 10.5% stake in Sydney Transport Partners (WestConnex)
    • Total cash consideration for the deal is $4.5 billion
    • Post-acquisition: 75% of NWRG and 60.5% of STP owned by Transurban
    • Funding via new committed debt facilities—no equity raising required
    • No expected impact on FY27 free cash and distributions

    What else do investors need to know?

    The acquisition is set to boost Transurban’s weighted average concession life, with asset concessions running as long as 2060. There will be no change to tolls or the daily experience for NSW motorists—only the economic interest splits among partners are changing.

    The deal must clear several regulatory and contractual conditions, including approval from the Australian Competition and Consumer Commission. Completion is anticipated during calendar 2027, with the final valuation set as of 31 March 2027.

    What did Transurban Group management say?

    Transurban CEO Michelle Jablko said:

    Sydney is a core market for Transurban. WestConnex, Westlink M7 and NorthConnex provide options for Sydney motorists as they move around the city and will play an important role in supporting Sydney’s growth for decades to come. We remain disciplined with how we allocate capital in our key markets of Australia and North America and we are committed to maintaining strong investment grade credit metrics.

    What’s next for Transurban Group?

    Transurban expects to complete the acquisition in 2027 after securing all necessary approvals. The company has stressed its continuing commitment to strong credit metrics and investment-grade ratings, planning to refinance the acquisition debt into longer-term facilities over time.

    Management highlighted that no equity raising is required and that the acquisition is expected to drive long-term growth in free cash per security, with only a minor short-term impact initially.

    Transurban Group share price snapshot

    Over the past 12 months, Transurban shares have declined 4%, trailing the S&P/ASX 200 Index (ASX: XJO), which has declined 1% over the same period.

    View Original Announcement

    The post Transurban Group share price: $4.5bn deal for bigger Sydney road stakes appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Transurban Group right now?

    Before you buy Transurban Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Transurban Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Transurban Group. The Motley Fool Australia has positions in and has recommended Transurban Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Financial statement inaccuracy

  • PFE | Pfizer and German partner BioNTech SE said Tuesday they’ve begun delivering doses of their coronavirus vaccine to US candidates with trials in Germany already underway.

  • PFE | Pfizer and German Parker BioNTech SE have begun delivering doses of their coronavirus vaccine for human testing US, trials in Germany already underway.

  • The performance outlook of tech companies.